Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Ro Mind
Patients can now get anxiety and depression medications via Ro's direct-to-consumer platform
By
Laura Lovett
|
12:44 pm |
July 27, 2021
The platform, called Ro Mind, lets users fill out an assessment and then consult with a clinician.